IPCA Laboratories Ltd IPCALAB-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 03/05/21 IST
1,923.45quote price arrow down-11.25 (-0.58%)
Volume
231,439
52 week range
1,200.00 - 2,460.00

...

Loading . . .

KEY STATS

  • Open1,913.10
  • Day High1,927.80
  • Day Low1,908.30
  • Prev Close1,934.70
  • 52 Week High2,460.00
  • 52 Week High Date10/28/20
  • 52 Week Low1,200.00
  • 52 Week Low Date03/19/20
  • Market Cap3,179.09M
  • Shares Out126.85M
  • 10 Day Average Volume270,635.09
  • Dividend9.67
  • Dividend Yield0.50%
  • Beta
  • 1 Year % Change33.99

RATIOS/PROFITABILITY

  • EPS (TTM)84.24
  • P/E (TTM)22.83
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date11/13/2020
  • Div Amount8.00
  • Split Date-
  • Split Factor-

Latest IPCA Laboratories Ltd News

There is no recent news for this security.

Latest IPCALAB-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid and Folitrax. Its 3c division focuses on cardiovascular and anti-diabetic markets. Its 3d division is...
Premchand Godha
Chairman
Ajit Jain
Chief Financial Officer
Address
142 AB, Kandivli Industrial Estate
Kandivli (West)
Mumbai
400067
India